Human Papillomavirus (HPV) Genotyping

Discover the latest on Medi Linx Laboratory

KNOW OUR DIRECTORY OF SERVICES

Explore our comprehensive test menu covering a wide range of medical specialties to support accurate diagnoses and patient management. From routine chemistry to advanced genomics—we’ve got you covered.

Human Papillomavirus (HPV) Genotyping

Test Information:
HPV-DNA assay is intended to detect HPV-16, HPV18/45 genotypes and 11 other high risk types (31, 33,35, 39, 51, 52, 56, 58, 59, 66 and 68). Persistent infection with high risk human papillomavirus (HPV) is the main cause of cervical cancer and is a precursor to cervical intraepithelial neoplasia (CIN).

Specimen Container:

  • SurePath
  • PreservCyt Solution

Specimen Type:
Cervical Specimen

Required Volume:
10 mL

Patient Preparation:
No Patient Preparation

Notes:
Do Not Freeze!

Storage & Stability
(Before Processing)

  • Storage: 2 to 8°C
    Stability: 2  weeks

Transport Temperature:
Ref (2°C to 8°C)

Test Category:
Routine

Test Schedule:
Effective may 04, 2026
Running day: Monday – Friday (cut-off: 1500H)

Results Availability:
Effective May 04, 2026
Within 24Hrs:
Specimen received before 1500H (Monday to Friday)
Next day:
Specimen received 1501H onwards (Monday to Thursday)
Monday:
Specimen received 1501H onwards (Friday)

At MEDI LINX LABORATORY INC., we are committed to safeguarding the privacy and security of your personal and health-related information. This data privacy statement outlines how we collect, use, disclose, and protect your data to ensure compliance with applicable laws and regulations, including but not limited to Republic Act No. 10173, its Implementing Rules and Regulations, and the issuance/s set forth by the National Privacy Commission (NPC).

Click here to read the Data Privacy Statement in full.